The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

The developmental mechanisms of gastric cancer and esophageal adenocarcinoma - The developmental mechanisms of gastric cancer and esophageal adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004004

Enrollment

200

Registered

2010-08-06

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer,esophageal adenocarcinoma Barrett&#39

Interventions

H. pylori eradication triple therapy 1 week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with Barrett's esophageal epithelium and the patietns with endoscopic resection for early gastric cacner and H. pylori eradication

Exclusion criteria

Exclusion criteria: taking NSAIDs history of gastrectomy or eradication haemorrhagic diseases insulin dependent diabetes mellitus cirrhosis renal failure

Design outcomes

Primary

Measure	Time frame
Genes expressions including the micro RNA in the patients with Barrett's esophageal epithelium or gastric cancer after endoscopic resection before and after H. pylori eradication	—

Secondary

Measure	Time frame
comparison of gene expression in the Barrett epithelium between American and Japanese	—

Countries

Japan,North America

Contacts

Public ContactAkiko shiotani

Kawasaki Medical School Gastroenterology

shiotani@med.kawasaki-m.ac.jp81-86-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026